Our Company Features
Most advanced adhesion and delivery system
Proprietary patch technology optimizes drug delivery through the skin.
Anti-inflammatory oral solution delivers individualized dosing
Precision dosing in high risk patients.
The only liquid ready-to-use analgesic formulated in a proprietary delivery system
Delivers fast and long lasting migraine relief.
About Us
Leader in non-opioid pain management products
Scilex Holding Company (Nasdaq: SCLX) is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and becoming the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products that maximize quality of life.
About Us
Leader in non-opioid pain management products
Scilex Holding Company (Nasdaq: SCLX) is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life.
Product Portfolio
OPTIMIZE QUALITY OF LIFE THROUGH PHARMACEUTICALS
Testimonals
Topical Delivery Systems Effectively Transport Analgesics to Areas of Localized Pain via Direct Diffusion
Pain Freedom With Celecoxib Oral Solution, Ubrogepant, and Rimegepant Through 4 Hours Postdose
Corporate Presentation
Scilex Holding Company Corporate Presentation
Download here »
April 16, 2024
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses
Read More »Do you have any questions? Lets talk!
650-516-4310